| abstract |
The present invention determines the level of complement pathway components in erythrocytes, thereby causing an inflammatory disease or condition (e.g., an immune disease or an immunological condition, a blood disease or a hematological condition, a vascular disease or a vascular condition, Or relates to the diagnosis and / or monitoring of patients with infectious diseases or conditions. Also disclosed in the present invention is a method of diagnosing vascular disease or vascular condition by determining the level of complement pathway components in platelets. |